ASCLS eNewsBytes

• FDA Approves Monthly KwikPen Option for Tirzepatide in Chronic Weight Management March 3, 2026
  The FDA has expanded the label for tirzepatide, permitting a 4-dose, single-patient-use KwikPen that provides a month's treatment for chronic weight management.
• Imaging Technique Can Reduce Benign Breast Biopsies by 25% March 3, 2026
  In breast cancer diagnosis, a biopsy is essential to confirm cancer presence, yet 75% to 80% of such biopsies in the U.S. find benign results. A clinical trial with 226 patients tested ultrasound-guided diffuse optical tomography technology to see if it could lower the rate of benign breast biopsies.
• Scientists Reverse Blood Stem Cell Aging by Rewiring the Cell's Recycling System March 3, 2026
  Researchers have discovered a method to rejuvenate aging blood-forming stem cells in mice by addressing issues in their lysosomes, revealing that excessive lysosomal activity and damage significantly contribute to stem cell aging.
• FDA Approves Dupilumab for Allergic Fungal Rhinosinusitis in Patients 6 Years and Older March 3, 2026
  Dupilumab is the first and only medication approved by the FDA for allergic fungal rhinosinusitis in patients aged six years and older.
• Children With Sleep Apnea Face Higher Risk of Flu and COVID-19 March 3, 2026
  A new study reveals a significant association between pediatric obstructive sleep apnea and an increased vulnerability to viral infections.